Bank of America
GNOM icon

Bank of America’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bank of America’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-350
Closed -$17K – 7834
2023
Q2 		$17K Hold
350
– – ﹤0.01% 6748
2023
Q1 		$17.2K Hold
350
– – ﹤0.01% 6792
2022
Q4 		$17.7K Buy
+350
New +$18K ﹤0.01% 6770

Other funds holding GNOM

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return

Bank of America's GNOM Position: Q1 2026 in Review

Bank of America increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 68% in Q1 2026, buying an estimated $2.24M and bringing the position to 119,795 shares worth $5.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3427.

Bank of America first reported a position in GNOM in Q4 2020 and has held it in 22 quarters since. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

  • Bank of America held 119,795 shares of Global X Genomics & Biotechnology ETF worth $5.24M as of Q1 2026.
  • Bank of America bought 48,394 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $2.24M.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3427 holding.
  • Bank of America first reported a position in Global X Genomics & Biotechnology ETF in Q4 2020 and has held it in 22 quarters since.
  • 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.